Search results
7 gru 2021 · It targets the B cell maturation antigen (BCMA) on plasma cells and showed promising results in several randomized clinical trials. We report the outcomes of 36 patients treated at Mayo...
- Full Size Table
Chętnie wyświetlilibyśmy opis, ale witryna, którą oglądasz,...
- Articles
Browse the archive of articles on Blood Cancer Journal....
- RSS Feed
Progression of disease within 24 months (POD24) in...
- Sign up for Alerts
Chętnie wyświetlilibyśmy opis, ale witryna, którą oglądasz,...
- Contact
Publishing staff. The Publishing Manager of Blood Cancer...
- News & Comment
Read the latest News & Comment articles from Blood Cancer...
- Full Size Table
30 lip 2022 · StarUMLVSLucid Visual Collaboration Suite. Compare StarUML ratings to similar products. Filter 24 reviews by the users' company size, role or industry to find out how StarUML works for a business like yours.
1 lip 2024 · 1) Demonstrate which women benefit from menopausal hormone therapy; 2) Identify nonhormone options for women who cannot use or choose not to use hormone therapy. 3) Utilize nonhormone options that treat more than one symptom in midlife women experiencing menopausal symptoms.
10 gru 2021 · Learning Objectives. Review of current clinical risk scores for myeloma precursor conditions, which are limited indirect measures of disease burden/activity. Show how low-input WGS reveals striking differences and existence of 2 biologically and clinically distinct entities. CLINICAL CASE.
2 mar 2021 · In the current study, we share our 14 years’ real-life experience in 1123 consecutive and cytogenetically annotated adult AML patients seen at the Mayo Clinic.
StarUML is a sophisticated UML modeling tool designed to facilitate the creation and management of complex software models. It supports a wide range of UML diagrams, including class, sequence, and use case diagrams, making it an invaluable resource for software developers, system architects, and project managers.
25 sie 2021 · The new criteria require substantial impairment in function accompanied by fatigue, PEM, unrefreshing sleep, and either cognitive impairment or orthostatic intolerance (Figure). Symptoms should be of at least moderate intensity and present at least 50% of the time during a 6-month period.
